Chronic Heart Failure to Boost Future Growth Today's Medical Developments Although the renal denervation market has previously been focused on the intervention's treatment of patients with resistant and uncontrolled hypertension, it is expected that the next approved indication will be in chronic heart failure patients, says ... |
